Dr. Pingping Wu 吴平平
Chief Physician
Department of Medical Oncology, Jiangsu Cancer Hospital, Nanjing
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Diagnosis and standardized comprehensive treatment of breast cancer, gastrointestinal tumors, lung cancer, and other malignancies. Management and prevention of tumor-related complications and critical emergencies.
Dr. Wu holds a medical doctorate and serves as Chief Physician. The doctor has led or participated in multiple research projects, published over ten papers in domestic and international journals, and received the Second Prize for New Technology Introduction from the Provincial Health Department.
Name order: in Chinese the family name comes first (Wu Pingping). Papers usually list the name as Pingping Wu or Wu P.
Selected publications
21 papers on PubMed matched by name and affiliation; 6 as first or senior author since 2016. Most recent first- or senior-author papers:
- BMC Cancer, 2026 (first author): Retraction Note: Enhanced antitumor efficacy in colon cancer using EGF functionalized PLGA nanoparticles loaded with 5-Fluorouracil and perfluorocarbon. PubMed 42632895
- Front Genet, 2022 (first author): Screening prognostic genes related to leucovorin, fluorouracil, and irinotecan treatment sensitivity by performing co-expression network analysis for colon cancer. PubMed 36523769
- BMC Cancer, 2020 (first author): Enhanced antitumor efficacy in colon cancer using EGF functionalized PLGA nanoparticles loaded with 5-Fluorouracil and perfluorocarbon. PubMed 32345258
- Int J Nanomedicine, 2020 (first author): Combined Therapeutic Effects of (131)I-Labeled and 5Fu-Loaded Multifunctional Nanoparticles in Colorectal Cancer. PubMed 32368054
- J Biomed Res, 2018 (senior author): Association of serum lipids and severity of epithelial ovarian cancer: an observational cohort study of 349 Chinese patients. PubMed 30249816
- Biomater Sci, 2016 (senior author): Theranostics for hepatocellular carcinoma with Fe3O4@ZnO nanocomposites. PubMed 26523294
- J BUON, 2015 (first author): A meta-analysis of MTRR A66G polymorphism and colorectal cancer susceptibility. PubMed 26214647
- Drug Des Devel Ther, 2014 (first author): Design real-time reversal of tumor multidrug resistance cleverly with shortened carbon nanotubes. PubMed 25525333
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion